| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.6 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |